# Junta clínica — PT-pseudo_87cbc2052e90 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_87cbc2052e90",
  "pid": "PT-pseudo_87cbc2052e90",
  "task": 1,
  "psa": 8.8,
  "age": 70,
  "months": 1,
  "pirads": "3",
  "psad": 0.267,
  "psav": 0.96,
  "psap": 8.5,
  "vol": 33.02,
  "dre": "Normal",
  "bx": "None",
  "cspca": 0.7255827,
  "medhx": "Hypertension, Chronic kidney disease, Benign prostatic hyperplasia",
  "meds": "amlodipine, valsartan, lisinopril, metoprolol, tamsulosin",
  "notes": "PSA 8.8 ng/mL. PI-RADS 3. PSAD 0.27. Prostate volume 33 mL. csPCa 0.73.",
  "pmhx": [
    "Hypertension",
    "Chronic kidney disease",
    "Benign prostatic hyperplasia"
  ],
  "allergies": [],
  "vitals": {
    "weight": "69 kg",
    "height": "166 cm",
    "bmi": "25.0",
    "bp": "141/71 mmHg",
    "hr": "64 bpm",
    "smoking": "Ex-smoker (36 pack-yr, quit 2020)",
    "last_dental": "3 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "22 Jan 2025",
  "enc_ref": "Dr. K. Bakker (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Urgent evaluation sought after a marked elevation in prostate-specific antigen to 8.8 ng/mL accompanied by recent multiparametric MRI results."
    },
    {
      "s": "History",
      "t": "At seventy years of age, this retired warehouse worker originally sought urological care three years ago for urinary complaints, though current attendance focuses entirely on monitoring a rising prostate-specific antigen trajectory. His medical background encompasses hypertension, chronic kidney disease, and benign prostatic hyperplasia, currently addressed with amlodipine, valsartan, lisinopril, metoprolol, and tamsulosin. Lower urinary tract distress remains minimal, yielding an International Prostate Symptom Score of 2 out of 35, while he explicitly denies hematuria or erectile dysfunction. He shares a ground-floor apartment with his wife, navigates daily tasks using seated exercise programs due to restricted mobility, and ingests roughly five alcoholic beverages each week. A former smoker with a 36 pack-year accumulation, he ceased tobacco use in 2020. Preventive health maintenance includes routine dental visits and recent ophthalmologic evaluation for cataract tracking. Surgical history features a laparoscopic cholecystectomy completed twenty years ago and a minor arthroscopic knee procedure in 2018, both healed without complications. He reports zero instances of bone pain, unexplained weight reduction, or systemic illness, maintaining steady general health."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: uniformly smooth; size and consistency: within normal limits; asymmetry or nodularity: absent. General assessment shows no abnormalities, recording a blood pressure of 141/71 mmHg and a steady cardiac rhythm at 64 beats per minute. Peripheral tissues lack edema, and no lymph node enlargement is detected. Abdominal palpation identifies a relaxed, non-tender cavity without distension."
    }
  ],
  "occupation": "retired warehouse worker",
  "marital": "Married",
  "living": "Lives in ground-floor apartment with partner",
  "next_of_kin": "Sibling (sister)",
  "recent_other": [
    "Dental — biannual check-up",
    "Ophthalmology — cataract review"
  ],
  "alcohol": "5 units / week",
  "exercise": "Limited mobility — chair-based exercises only",
  "ipss": "IPSS score: 2/35 (mild LUTS)",
  "admin": "Patient self-employed; flexible appointment slots requested.",
  "mri_hospital": "OLVG (Amsterdam)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_87cbc2052e90
Task: 1

Encounter: Urology - outpatient on 22 Jan 2025.
Referrer: Dr. K. Bakker (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 70-year-old male
  - PSA: 8.8 ng/mL
  - mpMRI — PI-RADS score: 3 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.267 ng/mL²
  - PSA velocity: 0.96 ng/mL/yr
  - Prior PSA: 8.5 ng/mL
  - Prostate volume: 33.02 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.7255827 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Hypertension, Chronic kidney disease, Benign prostatic hyperplasia
  - Problem list / PMHx: Hypertension, Chronic kidney disease, Benign prostatic hyperplasia
  - Current medication: amlodipine, valsartan, lisinopril, metoprolol, tamsulosin
  - Allergies: NKA
  - Additional notes: PSA 8.8 ng/mL. PI-RADS 3. PSAD 0.27. Prostate volume 33 mL. csPCa 0.73.

Vitals: weight 69 kg, height 166 cm, BMI 25.0, BP 141/71 mmHg, HR 64 bpm. Smoking: Ex-smoker (36 pack-yr, quit 2020).

Chief complaint: Urgent evaluation sought after a marked elevation in prostate-specific antigen to 8.8 ng/mL accompanied by recent multiparametric MRI results.

History: At seventy years of age, this retired warehouse worker originally sought urological care three years ago for urinary complaints, though current attendance focuses entirely on monitoring a rising prostate-specific antigen trajectory. His medical background encompasses hypertension, chronic kidney disease, and benign prostatic hyperplasia, currently addressed with amlodipine, valsartan, lisinopril, metoprolol, and tamsulosin. Lower urinary tract distress remains minimal, yielding an International Prostate Symptom Score of 2 out of 35, while he explicitly denies hematuria or erectile dysfunction. He shares a ground-floor apartment with his wife, navigates daily tasks using seated exercise programs due to restricted mobility, and ingests roughly five alcoholic beverages each week. A former smoker with a 36 pack-year accumulation, he ceased tobacco use in 2020. Preventive health maintenance includes routine dental visits and recent ophthalmologic evaluation for cataract tracking. Surgical history features a laparoscopic cholecystectomy completed twenty years ago and a minor arthroscopic knee procedure in 2018, both healed without complications. He reports zero instances of bone pain, unexplained weight reduction, or systemic illness, maintaining steady general health.

Physical examination: DRE — texture: uniformly smooth; size and consistency: within normal limits; asymmetry or nodularity: absent. General assessment shows no abnormalities, recording a blood pressure of 141/71 mmHg and a steady cardiac rhythm at 64 beats per minute. Peripheral tissues lack edema, and no lymph node enlargement is detected. Abdominal palpation identifies a relaxed, non-tender cavity without distension.

Patient info: retired warehouse worker; Married; Lives in ground-floor apartment with partner.
Next of kin: Sibling (sister).

Lifestyle: alcohol 5 units / week; exercise Limited mobility — chair-based exercises only; IPSS score: 2/35 (mild LUTS).

Recent other appointments: Dental — biannual check-up; Ophthalmology — cataract review.
Admin: Patient self-employed; flexible appointment slots requested.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.56
  uncertainty  +/- 0.13 epistemic (95% band 0.30-0.81); among patients I cannot tell apart the outcome was 0.99 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

What moved me most, across the labelled series: prior positive biopsy, PI-RADS >= 4, no prior biopsy, pmhx_hypercholesterolaemia, suspicious DRE, number of comorbidities. I read 39 variables, all
from the panel — nothing from the mpMRI prose, the PSA trajectory, the previous notes or the
laboratory. Out-of-fold over 91 labelled cases: AUC 0.758, balanced
accuracy 0.625.

The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 24 labelled men in this same situation (None prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.91: PI-RADS 4, PSA 9.3, PSAD 0.296, age 66, DRE Normal -> BIOPSY (clear). He wrote: "P4 in 66 year old patient."
  2. distance 2.31: PI-RADS 4, PSA 13.9, PSAD 0.177, age 65, DRE Normal -> BIOPSY (clear). He wrote: "P4 in 65 year old patient"
  3. distance 2.43: PI-RADS 2, PSA 5.0, PSAD 0.1, age 77, DRE Normal -> DEFER (clear). He wrote: "older patient with non-elevated, stable PSA. some comorbidity limits expected survival. MRI without significant lesions. Low risk of higher risk prostate cancer -> no bi…"

PRECEDENT: BIOPSY (weighted vote 0.70 for biopsy). Distance-weighted precedent is strong here (0.92 leave-one-out).

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 24 labelled traces in this situation (None prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.
WHAT HE WEIGHS: bx=important, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted.
HOW SURE HE USUALLY IS: clear.

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines suggest that a PI-RADS score of 3 mandates a biopsy, especially when clinical suspicion of prostate cancer is present. The guideline states, "When MRI is indeterminate (PI-RADS = 3), and clinical suspicion of PCa is very low (PSA density < 0.10 ng/mL/cc and no family history), omit biopsy and offer PSA monitoring."

WHAT THE EXPERTS' BIDS DO NOT SETTLE
Expert-Structured's suggestion of biopsy is not decisive because the guideline makes the decision contingent on the PSA density threshold, which is a specific value on the panel. Expert-Cohort's criterion is insufficient because it only confirms the general rule for PI-RADS 3 or higher, without accounting for the specific PSA density value provided.

WHAT WE STILL NEED
The guideline requires confirmation of the PSA density value to determine if biopsy should be omitted. The panel shows the PSA density is 0.267 ng/mL², which is above the threshold of 0.10 ng/mL/cc mentioned in the guideline for omitting biopsy when suspicion is low. The prior biopsy status is documented as "None," which is a fact that the guideline makes decisive regarding the need for a new procedure.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on whether the elevated PSA density warrants a biopsy despite the PI-RADS 3 finding, which the EAU guideline specifically addresses.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> What is the lesion size and zone described in the mpMRI prose?
  psa_trend (get_psa_trend) -> What is the trend of the serial PSA values?
  previous_notes (get_previous_notes) -> What is the management context regarding prior biopsy status, surveillance protocol, and planned treatment?
  laboratory_results (get_lab_results) -> What are the full panel results, including free-PSA fraction and renal function?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the specific finding from the radiology report regarding lesion size and zone to further inform the decision?

On the plan itself: Dropped 1 question(s) that asked for a value already printed on the panel: "Given the PI-RADS 3 score and the PSA density of 0.267 ng/mL², does the clinical suspicion of PCa meet the threshold required by the EAU guideline to mandate a biopsy?".

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
The lesion size and zone described in the mpMRI prose is: "a discrete region of intermediate signal intensity within the right posterior peripheral zone at the mid-gland, spanning roughly 8 by 6 mm."

psa_trend
The trend of the serial PSA values is: [{"date": "Dec 2023", "val": 1.3}, {"date": "Apr 2024", "val": 2.1}, {"date": "Jul 2024", "val": 3.4}, {"date": "Oct 2024", "val": 5.5}, {"date": "Jan 2025", "val": 8.8}].

previous_notes
The management context regarding prior biopsy status, surveillance protocol, and planned treatment is: "Prior biopsy: None. Surveillance: not recorded. Treatment: none recorded."

laboratory_results
The full panel results, including free-PSA fraction and renal function is: PSA: "8.8 ng/mL" on "31 Dec 2024" with flag "H"; Free PSA: "1.00 ng/mL" on "31 Dec 2024" with flag ""; %Free PSA: "11%" on "31 Dec 2024" with flag "L"; Creatinine: "103 umol/L" on "31 Dec 2024" with flag ""; eGFR: "<60 mL/min/1.73m2" on "31 Dec 2024" with flag "L".

WHAT I DID NOT OPEN
family-history anamnesis, because the EAU guideline analysis focused on the PSA density and prior biopsy status which were covered by other documents.

WHAT THIS SUPPORTS
Findings that argue FOR sampling this patient now:
PI-RADS score of 3 mandates a biopsy according to the EAU guideline.
The PSA density of 0.267 ng/mL/mL is above the threshold for omitting biopsy.

Findings that argue AGAINST sampling this patient now:
The EAU guideline suggests omitting biopsy if clinical suspicion is very low, which is not definitively established here.

WHERE THIS LEANS
The documents suggest a leaning towards biopsy due to the PI-RADS 3 finding and the PSA density exceeding the threshold mentioned in the EAU guideline.
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 8.80 ng/mL over 5 points spanning 13 months; velocity +6.78 ng/mL per year; doubling time about 5 months.
PROJECTION at 6 months: 13.2 ng/mL, conformal 95% band 3.8-45.9.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.57
  uncertainty  +/- 0.12 epistemic (95% band 0.33-0.81), of which 0.00 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

What moved me most across the labelled series: prior positive biopsy, no prior biopsy, free PSA < 15%, DWI restriction in the report, lesion >= 15 mm in the report, suspicious DRE. Out-of-fold AUC 0.794. I am the only expert that has read the report's wording, and I still cannot see the prior grade or the
surveillance history: those are in the notes, and the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.56  ('discuss' tier)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.57  ('discuss' tier, fusion_full)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=0.70  (k=3 precedents)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_3)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_ge_3) — carried by EXPERT-COHORT.
PANEL ANSWER: BIOPSY. It matched the reading urologist in 24 of 24 labelled cases in exactly this situation (never biopsied).

Confidence the trace model expects here: clear. Weights it expects: bx=important, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents opened by the registrar appear to have answered the moderator's question regarding the radiology report, as the registrar reported the lesion size and zone.

ALIGNMENT WITH THE PANEL
The retrieved finding, specifically the PI-RADS 3 score and the PSA density of 0.267 ng/mL², aligns with the PANEL-PROTOCOL's decision to proceed with a biopsy, as this aligns with the EXPERT-COHORT rule (PI-RADS $\ge 3$).

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the specific finding from the radiology report regarding lesion size and zone to further inform the decision? This was answered by the Registrar, who reported the finding as "a discrete region of intermediate signal intensity within the right posterior peripheral zone at the mid-gland, spanning roughly 8 by 6 mm."

WHAT CARRIES WEIGHT, AND WHY
The PI-RADS score of 3 is decisive as it fired the PANEL-PROTOCOL's rule. The PSA density of 0.267 ng/mL/mL is also relevant as it was used by the EAU guideline analysis to weigh against omitting biopsy.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy, as the evidence retrieved confirms the criteria that led the Panel-Protocol to its decision.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

Biopsy is recommended because the PI-RADS 3 score mandates sampling according to the cohort criterion, which has a strong track record in this scenario. This decision is supported by the elevated PSA density of 0.267 ng/mL/mL, which exceeds the threshold for deferral suggested by the EAU guideline analysis. The evidence converged on proceeding with a biopsy based on the imaging findings and the laboratory parameters.

What carried weight: bx=important, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Documents this conference opened: radiology_report, psa_trend, previous_notes, laboratory_results
